首页> 外文期刊>EuPA Open Proteomics >Quantitative analysis of the erythrocyte membrane proteins in polycythemia vera patients treated with hydroxycarbamide
【24h】

Quantitative analysis of the erythrocyte membrane proteins in polycythemia vera patients treated with hydroxycarbamide

机译:羟基尿素治疗真性红细胞增多症患者红细胞膜蛋白的定量分析

获取原文
           

摘要

More than 90% of polycythemia vera (PV) patients have a mutation in the protein JAK2, which is closely associated with the erythrocyte membrane. With the comparison of 1-D gels of erythrocyte membranes obtained from PV patients treated with hydroxycarbamide and those of untreated controls we observed significant differences in the region of 40-55kDa. On the basis of the LC-MS/MS analysis of this region we report up-regulation of four protein disulfide isomerases, which was subsequently confirmed by targeted mass spectrometric analysis. In further studies it will be prudent to compare this in patients both treated and not treated with hydroxycarbamide.
机译:超过90%的真性红细胞增多症(PV)患者的蛋白质JAK2有突变,该突变与红细胞膜密切相关。通过比较从接受羟基脲治疗的PV患者和未经治疗的对照获得的红细胞膜的1-D凝胶,我们观察到40-55kDa区域存在显着差异。在对该区域进行LC-MS / MS分析的基础上,我们报告了四种蛋白质二硫键异构酶的上调,随后通过靶向质谱分析证实了这一点。在进一步的研究中,比较用羟基尿素治疗和未用羟基尿素治疗的患者均应谨慎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号